![Computational approach to identify potential antileishmanial activity of reported inhibitor, E5700 and two natural alkaloids against Leishmania donovani Squalene Synthase | Experimental Results | Cambridge Core Computational approach to identify potential antileishmanial activity of reported inhibitor, E5700 and two natural alkaloids against Leishmania donovani Squalene Synthase | Experimental Results | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20200826154242184-0923:S2516712X20000374:S2516712X20000374_fig3.png?pub-status=live)
Computational approach to identify potential antileishmanial activity of reported inhibitor, E5700 and two natural alkaloids against Leishmania donovani Squalene Synthase | Experimental Results | Cambridge Core
![In Vitro and In Vivo Activities of E5700 and ER-119884, Two Novel Orally Active Squalene Synthase Inhibitors, against Trypanosoma cruzi | Antimicrobial Agents and Chemotherapy In Vitro and In Vivo Activities of E5700 and ER-119884, Two Novel Orally Active Squalene Synthase Inhibitors, against Trypanosoma cruzi | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/aac.48.7.2379-2387.2004/asset/228f196f-349f-4edd-87fe-af658ac3c5d2/assets/graphic/zac0070441500003.jpeg)
In Vitro and In Vivo Activities of E5700 and ER-119884, Two Novel Orally Active Squalene Synthase Inhibitors, against Trypanosoma cruzi | Antimicrobial Agents and Chemotherapy
![In Vitro and In Vivo Activities of E5700 and ER-119884, Two Novel Orally Active Squalene Synthase Inhibitors, against Trypanosoma cruzi | Antimicrobial Agents and Chemotherapy In Vitro and In Vivo Activities of E5700 and ER-119884, Two Novel Orally Active Squalene Synthase Inhibitors, against Trypanosoma cruzi | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/aac.48.7.2379-2387.2004/asset/e68dc523-9946-452f-a2b6-30795eabcd31/assets/graphic/zac0070441500006.jpeg)
In Vitro and In Vivo Activities of E5700 and ER-119884, Two Novel Orally Active Squalene Synthase Inhibitors, against Trypanosoma cruzi | Antimicrobial Agents and Chemotherapy
![In Vitro and In Vivo Activities of E5700 and ER-119884, Two Novel Orally Active Squalene Synthase Inhibitors, against Trypanosoma cruzi | Antimicrobial Agents and Chemotherapy In Vitro and In Vivo Activities of E5700 and ER-119884, Two Novel Orally Active Squalene Synthase Inhibitors, against Trypanosoma cruzi | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/aac.48.7.2379-2387.2004/asset/6bb47e81-71ac-40ac-87fb-3c5215446d19/assets/graphic/zac0070441500002.jpeg)
In Vitro and In Vivo Activities of E5700 and ER-119884, Two Novel Orally Active Squalene Synthase Inhibitors, against Trypanosoma cruzi | Antimicrobial Agents and Chemotherapy
![Computational approach to identify potential antileishmanial activity of reported inhibitor, E5700 and two natural alkaloids against Leishmania donovani Squalene Synthase | Experimental Results | Cambridge Core Computational approach to identify potential antileishmanial activity of reported inhibitor, E5700 and two natural alkaloids against Leishmania donovani Squalene Synthase | Experimental Results | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20200826154242184-0923:S2516712X20000374:S2516712X20000374_tab1.png?pub-status=live)